Publications by authors named "H Matsuno"
Visual hallucinations (VH) and pareidolia, a type of minor hallucination, share common underlying mechanisms. However, the similarities and differences in their brain regions remain poorly understood in Parkinson's disease (PD). A total of 104 drug-naïve PD patients underwent structural MRI and were assessed for pareidolia using the Noise Pareidolia Test (NPT) were enrolled.
View Article and Find Full Text PDFAssociation between sebum secretion and cardiac sympathetic dysfunction in Parkinson's disease.
Parkinsonism Relat Disord
December 2024
Background: Patients with Parkinson's disease (PD) have α-synuclein (α-Syn) deposition in the skin, and decreased sebum secretion due to epidermal dysfunction. However, the relationship between sebum secretion and autonomic neuropathies is unknown.
Methods: Using the medical records in our facility, we identified patients newly diagnosed with PD on admission from August 2020 to December 2023.
Article Synopsis
- - The study compared the accuracy of impressions taken of hypermobile teeth in partially edentulous dental arches using digital and conventional methods, assessing a mandibular model with three target teeth.
- - Results showed that digital impressions significantly outperformed hydrocolloid impressions for two of the three teeth tested, while the accuracy of digital and silicone impressions was similar.
- - The research concluded that using an intraoral scanner (digital method) is preferable for minimizing hypermobile tooth deviations compared to hydrocolloid impressions, with the accuracy varying based on the specific tooth's location.
Objectives: To document the utility of decremental responses in the repetitive nerve stimulation test (RNS) and spontaneous activities in needle electromyography (EMG) in the trapezius muscle for the diagnosis of amyotrophic lateral sclerosis.
Methods: Subjects were retrospectively identified from our EMG database. Cervical spondylosis was represented as a disease control group.
Objective: To assess safety of baricitinib in Japanese patients with rheumatoid arthritis in real-world clinical practice.
Methods: This all-case post-marketing surveillance study included patients initiating baricitinib for rheumatoid arthritis from September 2017 to April 2019. Treatment duration was recorded.